Cytotoxicity and modes of action of five Cameroonian medicinal plants against multi-factorial drug resistance of tumor cells

Abukhdeir, 2008, P21 and p27: roles in carcinogenesis and drug resistance, Expert Rev. Mol. Med., 10, e19, 10.1017/S1462399408000744 Adesina, 2005, The Nigerian zanthoxylum; chemical and biological values, Afr. J. Tradit. Comp. Altern. Med., 2, 282, 10.4314/ajtcam.v2i3.31128 Adesinan, 1982, The isolation and identification of anticonvulsant agents from Clausena anisata and Afraegle paniculata, Fitoterapia, 53, 63 Alley, 1988, Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay, Cancer Res., 48, 589 Azzariti, 2011, The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy, Curr. Drug Metab., 12, 713, 10.2174/138920011798357042 Bass, 1983, Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation, J. Immunol., 130, 1910, 10.4049/jimmunol.130.4.1910 Bedir, 2001, A new dammarane-type triterpene glycoside from Polyscias fulva, J. Nat. Prod., 64, 95, 10.1021/np0003589 Binkhathlan, 2013, P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives, Curr. Cancer Drug Targets, 13, 326, 10.2174/15680096113139990076 Bowen, 1985, An investigation of the stem bark of Bersama abyssinica, Planta Med., 51, 483, 10.1055/s-2007-969569 Bragado, 2007, Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation, Apoptosis, 12, 1733, 10.1007/s10495-007-0082-8 Bunz, 1999, Disruption of p53 in human cancer cells alters the responses to therapeutic agents, J. Clin. Invest., 104, 263, 10.1172/JCI6863 Bush, 2002, Cancer chemoresistance: the relationship between p53 and multidrug transporters, Int. J. Cancer, 98, 323, 10.1002/ijc.10226 Choi, 2014, ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development, Curr. Pharm. Des., 20, 793, 10.2174/138161282005140214165212 Cordell, 1991, Can ethnopharmacology contribute to development of new anti-cancer?, J. Ethnopharmacol., 32, 117, 10.1016/0378-8741(91)90110-Y Cossarizza, 2009, Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry, Nat. Protoc., 4, 1790, 10.1038/nprot.2009.189 Dandjesso, 2012, Phytochemistry and hemostatic properties of some medicinal plants sold as anti-hemorrhagic in Cotonou markets (Benin), Indian J. Sci. Technol., 5, 3105, 10.17485/ijst/2012/v5i8.10 Doyle, 1998, A multidrug resistance transporter from human MCF-7 breast cancer cells, Proc. Nat. Acad. Sci. U.S.A., 95, 15665, 10.1073/pnas.95.26.15665 Efferth, 2001, The human ATP-binding cassette transporter genes: from the bench to the bedside, Curr. Mol. Med., 1, 45, 10.2174/1566524013364194 Efferth, 2011, Natural products as inhibitors of epidermal growth factor receptor, Forum Immunopathol. Dis. Ther., 2, 281, 10.1615/ForumImmunDisTher.2012004386 Efferth, 1997, Apoptosis and resistance to daunorubicin in human leukemic cells, Leukemia, 11, 1180, 10.1038/sj.leu.2400669 Efferth, 2003, Identification of gene expression profiles predicting tumor cell response to l-alanosine, Biochem. Pharmacol., 66, 613, 10.1016/S0006-2952(03)00341-1 Efferth, 2000, Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation, Crit. Rev. Oncogenesis, 11, 165 Efferth, 2012, Autophagy by natural products in cancer cells, Biochem. Anal. Biochem., 1, 8, 10.4172/2161-1009.1000e128 Efferth, 2011, Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy, Curr. Drug Targets, 12, 122, 10.2174/138945011793591626 Efferth, 2008, Prediction of broad spectrum resistance of tumors towards anticancer drugs, Clin. Cancer Res., 14, 2405, 10.1158/1078-0432.CCR-07-4525 Efferth, 1989, Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors, Anticancer Res., 9, 1633 Efferth, 1992, Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors, Oncology, 49, 368, 10.1159/000227075 Efferth, 2003, Molecular modes of action of artesunate in tumor cell lines, Mol. Pharmacol., 64, 382, 10.1124/mol.64.2.382 Efferth, 1992, Antibody-directed therapy of multidrug-resistant tumor cells, Med. Oncol. Tumor Pharmacother., 9, 11, 10.1007/BF02989648 Efferth, 1993, Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms, Cancer Lett., 70, 197, 10.1016/0304-3835(93)90231-W Eichhorn, 2012, P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs, J. Ethnopharmacol., 141, 557, 10.1016/j.jep.2011.08.053 Eyong, 2005, Newbouldiaquinone and newbouldiamide: a new naphthoquinone−anthraquinone coupled pigment and a new ceramide from Newbouldia laevis, Chem. Pharm. Bull. (Tokyo), 53, 616, 10.1248/cpb.53.616 Focho, 2009, Medicinal plants of Aguambu—Bamumbu in the Lebialem highlands, southwest province of Cameroon, Afr. J. Pharm. Pharmacol., 3, 1 Gafner, 1996, Antifungal and antibacterial naphtoquinones from Newbouldia laevis roots, Phytochemistry, 42, 1315, 10.1016/0031-9422(96)00135-5 Gottesman, 2006, The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research, FEBS Lett., 580, 998, 10.1016/j.febslet.2005.12.060 1973 Hutchings, 1996 Gottesman, 2002, Mechanisms of cancer drug resistance, Ann. Rev. Med., 53, 615, 10.1146/annurev.med.53.082901.103929 Ito, 2009, Gamma-lactone carbazoles from Clausena anisata, J. Nat. Prod., 72, 1202, 10.1021/np800735m Jeruto, 2007, Herbal treatments in Aldai and Kaptumo divisions in Nandi district, Rift valley province, Kenya, Afr. J. Tradit. Comp. Altern. Med., 5, 103 Knappskog, 2012, P53 and its molecular basis to chemoresistance in breast cancer, Expert Opin. Ther. Targets, 16, S23, 10.1517/14728222.2011.640322 Konkimalla, 2009, The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate׳s activity in cancer cells, Curr. Cancer Drug Targets, 9, 72, 10.2174/156800909787314020 Kuete, 2010, Cameroonian medicinal plants: pharmacology and derived natural products, Front. Pharmacol., 1, 123, 10.3389/fphar.2010.00123 Kuete, 2011, Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy, J. Ethnopharmacol., 137, 752, 10.1016/j.jep.2011.06.035 Kuete, 2012, Cytotoxicity, anti-angiogenic, apoptotic effects and transcript profiling of a naturally occurring naphthyl butenone, guieranone A, Cell Div., 7, 16, 10.1186/1747-1028-7-16 Kuete, 2008, Antitumor, antioxidant and antimicrobial activities of Bersama engleriana (Melianthaceae), J. Ethnopharmacol., 115, 494, 10.1016/j.jep.2007.10.027 Kuete, 2013, Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2׳,5,6׳-tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol, Phytomedicine, 20, 528, 10.1016/j.phymed.2013.02.003 Kuete, 2011, Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants, PLoS One, 6, e21762, 10.1371/journal.pone.0021762 Kupchan, 1971, Tumor inhibitors. LXV. Bersenogenin, berscillogenin, and 3-epiberscillogenin, three new cytotoxic bufadienolides from Bersama abyssinica, J. Org. Chem., 36, 2611, 10.1021/jo00817a011 Lai, 2012, Tumour suppressor genes in chemotherapeutic drug response, Biosci. Rep., 32, 361, 10.1042/BSR20110125 Lambert, 2007, Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles׳ heel?, Adv. Exp. Med. Biol., 608, 52, 10.1007/978-0-387-74039-3_4 Lee, 2010, Influence of p53 expression on sensitivity of cancer cells to bleomycin, J. Biochem. Mol. Toxicol., 24, 260, 10.1002/jbt.20334 Leteurtre, 1994, Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen, J. Nat. Cancer Inst., 86, 1239, 10.1093/jnci/86.16.1239 Long, 2012, New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy, Oncogene, 31, 5045, 10.1038/onc.2012.7 Lowe, 1995, Cancer therapy and p53, Curr. Opin. Oncol., 7, 547, 10.1097/00001622-199511000-00013 Mabry, 1980, Chemistry and utilization of phenylpropanoids including flavonoids, coumarins, and lignans, J. Agric. Food Chem., 28, 188, 10.1021/jf60228a024 Marchetti, 2013, Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA, Invest. New Drugs, 31, 1125, 10.1007/s10637-013-9923-1 Martinez-Rivera, 2012, Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53, Biochem. Pharmacol., 83, 1049, 10.1016/j.bcp.2011.12.026 Mbaze, 2007, alpha-Glucosidase inhibitory pentacyclic triterpenes from the stem bark of Fagara tessmannii (Rutaceae), Phytochemistry, 68, 591, 10.1016/j.phytochem.2006.12.015 Nagane, 1998, Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases, Proc. Nat. Acad. Sci., 95, 5724, 10.1073/pnas.95.10.5724 Nakanishi, 2012, Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression, Chin. J. Cancer, 31, 73, 10.5732/cjc.011.10320 Natarajan, 2012, Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance, Biochem. Pharmacol., 83, 1084, 10.1016/j.bcp.2012.01.002 Nelson, 1997, In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium, J. Antimicrob. Chemother., 40, 305, 10.1093/jac/40.2.305 Ngadjui, 1991, Geranyl coumarins from Clausena anisata, Phytochemistry, 30, 2809, 10.1016/0031-9422(91)85155-S Njayou, 2008, Inhibition of microsomal lipid peroxidation and protein oxidation by extracts from plants used in Bamun folk medicine (Cameroon) against hepatitis, Afr. J. Tradit. Comp. Altern. Med., 5, 278 O׳Brien, 2000, Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity, Eur. J. Biochem., 267, 5421, 10.1046/j.1432-1327.2000.01606.x Ojewole, 2002, Hypoglycaemic effect of Clausena anisata (Willd) Hook methanolic root extract in rats, J. Ethnopharmacol., 81, 231, 10.1016/S0378-8741(02)00085-5 Paull, 1989, Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm, J. Nat. Cancer Inst., 81, 1088, 10.1093/jnci/81.14.1088 Popoca, 1998, Cytotoxic activity of selected plants used as antitumorals in Mexican traditional medicine, J. Ethnopharmacol., 59, 173, 10.1016/S0378-8741(97)00110-4 Rubinstein, 1990, Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines, J. Nat. Cancer Inst., 82, 1113, 10.1093/jnci/82.13.1113 Santos, 2013, Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of action, Curr. Cancer Drug Targets, 13, 814, 10.2174/15680096113139990082 Sau, 2010, Glutathione transferases and development of new principles to overcome drug resistance, Arch. Biochem. Biophys., 500, 116, 10.1016/j.abb.2010.05.012 Sayers, 2011, Targeting the extrinsic apoptosis signaling pathway for cancer therapy, Cancer Immunol. Immunother., 60, 1173, 10.1007/s00262-011-1008-4 Scherf, 2000, A gene expression database for the molecular pharmacology of cancer, Nat. Genet., 24, 236, 10.1038/73439 Schrattenholz, 2010, Systems biology approaches and tools for analysis of interactomes and multi-target drugs, Methods Mol. Biol., 662, 29, 10.1007/978-1-60761-800-3_2 Senthilkumar, 2009, Phytochemical analysis and antibacterial activity of the essential oil of Clausena anisata (Willd.) Hook. F. ex Benth, Int. J. Integr. Biol., 5, 116 Shien, 2013, Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells, Cancer Res., 73, 3051, 10.1158/0008-5472.CAN-12-4136 Singh, 2012, Role of glutathione in cancer pathophysiology and therapeutic interventions, J. Exp. Ther. Oncol., 9, 303 Sonneveld, 1997, Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts, Leukemia, 11, 1160, 10.1038/sj.leu.2400680 Staunton, 2001, Chemosensitivity prediction by transcriptional profiling, Proc. Nat. Acad. Sci. U.S.A., 98, 10787, 10.1073/pnas.191368598 Suffness, 1990 Tshibangu, 2002, Screening of African medicinal plants for antimicrobial and enzyme inhibitory activity, J. Ethnopharmacol., 80, 25, 10.1016/S0378-8741(01)00409-3 Usman, 2007, Phytochemical and in vitro antimicrobial assay of the leaf extract of Newbouldia laevis, Afr. J. Tradit. Comp. Altern. Med., 4, 476, 10.4314/ajtcam.v4i4.31240 Volm, 1992, Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations, Anticancer Res., 12, 11 Volm, 1993, Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas, Cancer, 71, 3981, 10.1002/1097-0142(19930615)71:12<3981::AID-CNCR2820711231>3.0.CO;2-A Volm, 2002, Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients, Clin. Cancer Res., 8, 1843 Wöll, 2013, Animal plant warfare and secondary metabolite evolution, Nat. Prod. Bioprospect., 3, 1, 10.1007/s13659-013-0004-0